With full nationwide interstate banking coming next year, Central Fidelity Banks Inc., Richmond, has strengthened its "poison pill" defenses against a hostile takeover.

Central Fidelity, which is often touted as a prime acquisition candidate, said Thursday it had modified its rights agreement to make it more difficult for someone to acquire a controlling interest in the bank.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.